Prominent researchers from public and private entities jointly lead ILSI.

The individuals who serve on the ILSI Board of Trustees bring a range of expertise, experience, and perspective to their work defining and achieving ILSI's goals. These individuals are unpaid volunteers who take their scientific and fiduciary responsibilities to the organization seriously. They serve on the ILSI Board of Trustees as individuals and do not represent their employers.

Peter van Bladeren, PhD
ILSI President
Nestlé
Switzerland
Professor Alan Boobis, OBE
Chair of the ILSI Board of Trustees
Imperial College London
United Kingdom
Todd Abraham, PhD
Mondelēz
USA
Joanne Lupton, PhD
Texas A&M University
USA
Scott Belanger, PhD
Procter & Gamble
USA
Teruo Miyazawa, PhD
Tohoku University
Japan
Ary Bucione
Dupont
Brazil
John O'Brien, PhD
Nestlé
Switzerland
Sushila Chang, PhD
Griffith University
Australia
Timothy Pastoor, PhD, DABT
on behalf of Syngenta Crop Protection
USA
Michael Doyle, PhD
University of Georgia
USA
Professor Dr Gerhard Rechkemmer
Max Rubner-Institut
Germany
Adam Drewnowski, PhD
University of Washington
USA
Tracey Reynolds, PhD
Monsanto Company
USA
Professor Dr Gerhard Eisenbrand
University of Kaiserslautern
Germany
Ivonne Rietjens, PhD
Wageningen University
The Netherlands
Catherine Field, PhD
University of Alberta
Canada
B. Sesikeran, MD
National Institute of Nutrition
India
Ernie Harpur, PhD
Newcastle University
United Kingdom
Geoff Smith
Nutrition Strategies International
Singapore
Lucy Hwang, PhD
National Taiwan University
Taiwan
Professor Lewis Smith
University of Leicester
United Kingdom
Takeshi Kimura, PhD
Ajinomoto Co., Inc.
Japan
Sara Valdéz Martinez, PhD
Universidad Nacional Autónoma de México
México
Ik-Boo Kwon, PhD
Lotte Company
Korea
Connie Weaver, PhD
Purdue University
USA
Serrine Lau, PhD
Wayne State University
USA
Peter Weber, MD, PhD
DSM
Switzerland
Josette Lewis, PhD
University of California, Davis
USA
Elizabeth Westring, PhD
General Mills, Inc.
USA
Flávio Zambrone, PhD
Planitox
Brazil

ILSI's funding comes primarily from its corporate membership and supporting companies.

We are grateful to the companies who make it financially possible for ILSI to achieve its mission to provide science that makes the world a healthier, safer place. 2015 Member and Supporting Companies


2014 Financial Snapshot
The ILSI branches and the ILSI Research Foundation are separate legal entities affiliated with ILSI corporate through individual charter agreements. The branches have independent accounting departments and follow accounting principles standard in their home countries.

An aggregate of financial information for ILSI corporate, the ILSI branches, and the ILSI Research Foundation is presented here. Although ILSI corporate does not audit the information submitted by the branches for this report, it is a best estimate of global financial activity.

2014 Total Revenue:   $US 21,928,653
2014 Total Expenses:  $US 19,758,886

2015 and 2014 Audited Consolidated Financial Statements for ILSI and Affiliate
The audited, consolidated financial statements for ILSI and the ILSI Research Foundation are posted here. These statements cover the ILSI governing and coordination functions managed by the headquarters office as well as the ILSI Research Foundation. These statements do not include the ILSI branches, which are independently incorporated in their home countries. ILSI does not own these branches; rather they are affiliated with ILSI through charter agreements.